Company intelligence / Profile preview

Sistemas Genómicos

Paterna, Valencia, Spainsistemasgenomicos.com ↗

Ownership: Private
Employees: ~100
Development stage: Preclinical

Overview

Sistemas Genómicos is a leading Spanish provider of genetic analysis, next-generation sequencing (NGS), and bioinformatics solutions for clinical diagnostics, research institutions, universities, and industry. It was acquired by SYNLAB in January 2022 to strengthen SYNLAB’s European leadership in genetics. The company is recognized for its expertise in DNA/RNA analysis throughout the human life cycle and has a strong track record in R&D collaborations[5][3][1].

Modalities: Diagnostic testNext generation sequencingBioinformatics analysis
Industry: Molecular Diagnostics

Partnerships

SYNLAB (acquirer/strategic partner)Ascires Grupo Biomédico (former parent group)Various universities/research centers via collaborative projects

Beyond the preview

Go deeper on Sistemas Genómicos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sistemas Genómicos.

Explore the full profile